Cargando…

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic

Background Sickle cell disease (SCD) is a hemoglobinopathy which manifests clinically as hemolytic anemia and recurrent episodes of pain caused by vaso-occlusion, among other symptoms. Vaso-occlusive crises (VOCs) account for an overwhelming majority of visits to the emergency room (ER) and hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Shivani, Yun, Nicole K., Coggan, James L., Wu, Peter, O'Brien, Teresa, Barnett, Katherine, O'Mahony, Sean, Kaur, Ramandeep, Bruti, Christopher, Goetz, Celine, Martin, Jerome J, Gezer, Sefer, Venugopal, Parameswaran, Jain, Shivi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	114.Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701419/ http://dx.doi.org/10.1182/blood-2021-151913

Ejemplares similares

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
por: Rao, Shivani, et al.
Publicado: (2021)

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic
por: Davila, Jennifer G., et al.
Publicado: (2020)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)

Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS)
por: Lam, Ho Pui Jeff, et al.
Publicado: (2020)

Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
por: Merz, Lauren E., et al.
Publicado: (2020)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
por: Abdelaal, Mahmoud A.Z., et al.
Publicado: (2020)

Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020)

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
por: Tanenbaum, Mira T, et al.
Publicado: (2019)

COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center
por: El Rassi, Fuad, et al.
Publicado: (2021)

COVID-19 in Hospitalized Patients with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2021)

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021)

Excess All-Cause Mortality in 2020 for People Living with Sickle Cell Disease in New York City
por: Curtis, Susanna A, et al.
Publicado: (2021)

Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience
por: Devarashetty, Sindhu, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease
por: Orkoulas-Razis, Dennis, et al.
Publicado: (2021)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

Profiling Dose-Dependent Activation of p53-Mediated Signaling Pathways by Chemicals with Distinct Mechanisms of DNA Damage
por: Clewell, Rebecca A., et al.
Publicado: (2014)

Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality
por: Grosse, Scott D., et al.
Publicado: (2011)

Impact of Blood Group Type on Severity of Disease in COVID-19 Patients
por: Rao, Shivani, et al.
Publicado: (2020)

Radiostereometric Evaluation of Tendon Elongation After Distal Biceps Repair
por: Marshall, Nathan E., et al.
Publicado: (2016)

Lateral Elbow Tendinopathy: Development of a Pathophysiology-Based Treatment Algorithm
por: Bhabra, Gev, et al.
Publicado: (2016)

Spanish Consensus Statement: Clinical Management and Treatment of Tendinopathies in Sport
por: Fernandez-Jaén, Tomas, et al.
Publicado: (2017)

Impact of blood type on thrombosis and disease severity in adult COVID-19 patients()
por: Rao, Shivani, et al.
Publicado: (2021)

Heparin Induced Thrombocytopenia in Patients with COVID-19
por: Warrior, Surbhi, et al.
Publicado: (2020)

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Prevention of Thromboembolic Events in Patients with COVID-19
por: Warrior, Surbhi, et al.
Publicado: (2021)

Intérêt d’une dose unique de Tocilizumab 400 mg sur les formes sévères d’infection respiratoire à COVID-19
por: Rossi, B., et al.
Publicado: (2020)

Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report
por: Alghamdi, Badria M., et al.
Publicado: (2020)

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
por: De Luna, Gonzalo, et al.
Publicado: (2020)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Immunothérapie dans le mélanome en hospitalisation à domicile : enquête de satisfaction et retour d’expérience des centres français d’oncodermatologie
por: Truong, Thao, et al.
Publicado: (2021)

Catheter ablation without fluoroscopy in pregnant with supraventricular tachycardia: substrate characterization and outcomes
por: Abdrakhmanov, A, et al.
Publicado: (2023)

Wave speed guided point-by-point cavo-tricuspid isthmus ablation to reduce ablation and fluoroscopy in typical atrial flutter
por: Rodriguez, O R, et al.
Publicado: (2023)

Outcomes of cavotricuspid isthmus-dependent fLutter ablation: randomized study comparing single vs multiple catheter procedures. The SIMPLE study
por: Falasconi, G, et al.
Publicado: (2023)

Cryoablation of atrioventricular nodal reentry tachycardia with utilization of three-dimensional electroanatomic mapping system
por: Podlogar, V, et al.
Publicado: (2023)

Impact of 3-dimensional electroanatomic mapping systems on fluoroscopy reduction in catheter ablation of supraventricular tachycardia - then and now
por: Chua, Y Y, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_drnr4mklol58r43gl6bkao5vk3